Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAT-1): Conditions and therapeutic targets

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Fibrinolysis and Proteolysis

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0268-9499(94)90229-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.

  2009cited by this paper
• Effect of moderate dose of alcohol with evening meal on fibrinolytic factors

  1994cited by this paper
• Prospective study of endogenous tissue plasminogen activator and risk of stroke.

  1994cited by this paper
• Fibrinolytic activity and arterial disease.

  1994cited by this paper
• Acute release of tissue-type plasminogen activator (t-PA) from the endothelium ; regulatory mechanisms and therapeutic target

  1994cited by this paper
• Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells.

  1994cited by this paper
• Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated.

  1994cited by this paper
• Insulin Therapy in Type 2 Diabetic Subjects Suppresses Plasminogen Activator Inhibitor (PAI‐1) Activity and Proinsulin‐like Molecules Independently of Glycaemic Control

  1993cited by this paper
• The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

  1993cited by this paper
• A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion, and endurance training.

  1993cited by this paper
• Predictive Value of Tissue Plasminogen Activator Mass Concentration on Long‐term Mortalit in Patients With Coronary Artery Disease A 7‐Year Follow‐up

  1993cited by this paper
• Antigens of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1: Correlates in Nonsmoking Japanese and Caucasian Men and Women

  1993cited by this paper
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

  1993cited by this paper
• Multicenter Evaluation of Commercially Available Methods for the Immunological Determination of Plasminogen Activator Inhibitor-1 (PAI-1)

  1993cited by this paper
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.

  1993cited by this paper
• Multicentre Evaluation of Commercial Kit Methods: Plasminogen Activator Inhibitor Activity

  1993cited by this paper
• Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen: A population study

  1993cited by this paper
• Insulin resistance and changes in haemostatic variables

  1992cited by this paper
• Effects of exercise training on plasminogen activator inhibitor activity.

  1992cited by this paper
• A Specific Immunologic Assay for Functional Plasminogen Activator Inhibitor 1 in Plasma – Standardized Measurements of the Inhibitor and Related Parameters in Patients with Venous Thromboembolic Disease

  1992cited by this paper
• A one‐step enzyme immunoassay for the determination of total tissue‐type plasminogen activator (t‐PA) antigen in plasma

  1992cited by this paper
• Bioimmunoassay for tissue-type plasminogen activator (t-PA) in human plasma: Evaluation of blood sampling and handling procedures and comparison with other t-PA activity methods

  1992cited by this paper
• Effect of age, time of day and arterial disease on the relation between tissue-type plasminogen activator and plasminogen activator inhibitor-1 in plasma

  1992cited by this paper
• Variability in information from a single venapuncture in healthy volunteers: Analysis of the haemostatic variables fibrinogen, Plasminogen Activator Inhibitor (PAI) activity and histidine-rich glycoprotein (HRG)

  1992cited by this paper
• Mechanisms of Tissue‐type Plasminogn Activator (tPA) Clearance by the Liver a

  1992cited by this paper
• Effects of Physical Conditioning on Fibrinolytic Variables and Fibrinogen in Young and Old Healthy Adults

  1991cited by this paper
• Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.

  1991cited by this paper
• Interrelationship between coagulant activity and tissue‐type plasminogen activator (t‐PA) system in acute ischaemic heart disease. Possible role of the endothelium

  1990cited by this paper
• The use of cultured human endothelial cells and hepatocytes as an in vitro model system to study modulation of endogenous fibrinolysis

  1990cited by this paper
• Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma.

  1990cited by this paper
• Disorders of the hemostatic system and the risk of the development of thrombotic and cardiovascular diseases: limitations of laboratory diagnosis.

  1990cited by this paper
• Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular disease.

  1990cited by this paper
• A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.

  1990cited by this paper
• Blood Collection in Strong Acidic Citrate Anticoagulant Used in a Study of Dietary Influence on Basal tPA Activity

  1989cited by this paper
• Mechanisms involved in short-term changes in blood levels of t-PA

  1988cited by this paper
• Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1).

  1988cited by this paper
• PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) ANTIGEN LEVELS IN HUMAN PLASMA SAMPLES

  1988cited by this paper
• Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke.

  1988cited by this paper
• A Selective Depression of Tissue Plasminogen Activator (t-PA) Activity in Euglobulins Characterises a Risk Group Among Survivors of Acute Myocardial Infarction

  1987cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.

  1987cited by this paper
• Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay.

  1986cited by this paper
• Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma

  1984cited by this paper
• Modulation of Rapid Plasminogen Activator Inhibitor in Plasma by Stanozolol

  1984cited by this paper

• Oxidative Stress, Hyperglycemia, Hyperlipidemia, and Hemostasis Impairment as Risk Factors for Diabetes in Rats: Investigating the Therapeutic Potential of Samwa (Cleome droserifolia)

  2025cites this paper
• Reishi Mushroom (Ganoderma lucidum) Intervention Improves Lipids Profile and Paraoxonase/Arylesterase Activities in Serum as well as Enhances Haemostatic Effects in Streptozotocin-Induced Diabetic Rats

  2022cites this paper
• RISK OF THROMBUS ASSOCATED DISEASE BY DETECTING ACERTAIN T-PA POLYMORPHISM

  2017cites this paper
• Diabetes Mellitus and Cardiovascular Risk : epidemiology, etiology and intervention

  2016cites this paper
• Hyperfibrinolysis during liver transplantation is associated with bleeding

  2015cites this paper
• Relation of PAI-1 and TPA Genes Polymorphisms to Acute Myocardial Infarction and its Outcomes in Egyptian Patients

  2014cites this paper
• ADIPOCYTE-DERIVED HORMONES AND CARDIOVASCULAR DISEASE

  2010cites this paper
• Portal Job strain and risk indicators for cardiovascular disease in young female nurses

  2010cites this paper
• The fibrinolytic enzyme system : New markers of potential interest in cardiovascular disease

  2005cites this paper
• Low level of tissue plasminogen activator activity in non‐diabetic patients with a first myocardial infarction

  2005cites this paper
• Diabetes as a procoagulant condition

  2002cites this paper
• Review: Diabetes as a procoagulant condition

  2002cites this paper
• Insulin Sensitivity and Hemostatic Factors in Clinically Healthy 58-year-old Men

  2000cites this paper
• Job strain and risk indicators for cardiovascular disease in young female nurses.

  2000cites this paper
• Job Strain and Risk Indicators for in Young Female

  2000cites this paper
• Tissue-type plasminogen activator (t-PA) activity

  1999cites this paper
• Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA.

  1999cites this paper
• Fibrinolytic Activity in Peripheral Atherosclerosis in the Elderly

  1999cites this paper
• Work stress and metabolic and hemostatic risk factors.

  1999cites this paper
• The mannose receptor, localization and role in the clearance of tissue-type plasminogen activator

  1998cites this paper
• Contribution of factor VII, fibrinogen and fibrinolytic components to the risk of ischaemic cardiovascular disease: their genetic determinants

  1998cites this paper
• Evaluation of a bioimmuno assay for t-PA activity and its relation to PAI-1 activity and antigen levels

  1998cites this paper
• The Effects of Sex Steroids on Plasma Levels of Marker Proteins of Endothelial Cell Functioning

  1998cites this paper
• Haemostasis and cardiovascular disease

  1997cites this paper
• Increased levels of tissue plasminogen activator antigen in essential hypertension. A population‐based study in Sweden

  1997cites this paper
• Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

  1997cites this paper
• In Vitro Clot Lysis as a Potential Indicator of Thrombus Resistance to Fibrinolysis – Study in Healthy Subjects and Correlation with Blood Fibrinolytic Parameters

  1997cites this paper
• Regulation of tissue-type plasminogen activator concentrations by clearance via the mannose receptor and other receptors

  1997cites this paper
• Relation of tissue-type plasminogen activator and plasminogen activator inhibitor to metabolic variables and atherosclerosis in a family cohort study

  1996cites this paper
• Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.

  1996cites this paper
• Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism

  1996cites this paper
• Diabetic angiopathy: tracking down the culprits.

  1996cites this paper
• Fibrinolytic capacity and risk of myocardial infarction

  1996cites this paper
• Consumption of reduced-fat products, haemostatic parameters and oral glucose tolerance test

  1996cites this paper
• Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.

  1995cites this paper
• The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine.

  1995cites this paper
• Job Strain and Risk Indicators for in Young Female

  year unknowncites this paper